Londhe P et al. |
CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells. |
2012 |
Int. J. Cancer |
pmid:21989738
|
Tsai KW et al. |
Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. |
2011 |
Int. J. Cancer |
pmid:21960261
|
Chen Y et al. |
Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer. |
2007 |
Int. J. Cancer |
pmid:17417779
|
Sato N et al. |
RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line. |
2007 |
Int. J. Cancer |
pmid:17096327
|
Bordonaro M et al. |
Cell type- and promoter-dependent modulation of the Wnt signaling pathway by sodium butyrate. |
2002 |
Int. J. Cancer |
pmid:11774242
|
Kikuchi T et al. |
Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer. |
2002 |
Int. J. Cancer |
pmid:11774276
|
Suzuki T et al. |
Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell lines. |
2000 |
Int. J. Cancer |
pmid:11093826
|
Kadowaki M et al. |
DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines. |
2012 |
Int. J. Cancer |
pmid:21437897
|
Feng W et al. |
Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer. |
2007 |
Int. J. Cancer |
pmid:17230502
|
Karam JA et al. |
The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy. |
2007 |
Int. J. Cancer |
pmid:17230511
|
Kikuno N et al. |
Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. |
2008 |
Int. J. Cancer |
pmid:18431742
|
Pluemsampant S et al. |
Protein kinase CK2 is a key activator of histone deacetylase in hypoxia-associated tumors. |
2008 |
Int. J. Cancer |
pmid:17935135
|
Yanaihara N et al. |
Reduced expression of MYO18B, a candidate tumor-suppressor gene on chromosome arm 22q, in ovarian cancer. |
2004 |
Int. J. Cancer |
pmid:15305387
|
Damjanovski S et al. |
Multiple stage-dependent roles for histone deacetylases during amphibian embryogenesis: implications for the involvement of extracellular matrix remodeling. |
2000 |
Int. J. Dev. Biol. |
pmid:11128570
|
Liang L et al. |
Dynamic readjustment of parental methylation patterns of the 5'-flank of the mouse H19 gene during in vitro organogenesis. |
2000 |
Int. J. Dev. Biol. |
pmid:11128572
|
Yoshida M |
Chemical genomics: a key to the epigenome - an interview with Minoru Yoshida. Interview by Saadi Khochbin. |
2009 |
Int. J. Dev. Biol. |
pmid:19412886
|
Yang F et al. |
Histone hyperacetylation during meiosis interferes with large-scale chromatin remodeling, axial chromatid condensation and sister chromatid separation in the mammalian oocyte. |
2012 |
Int. J. Dev. Biol. |
pmid:23417411
|
Tomita A et al. |
Epigenetic regulation of CD20 protein expression in a novel B-cell lymphoma cell line, RRBL1, established from a patient treated repeatedly with rituximab-containing chemotherapy. |
2007 |
Int. J. Hematol. |
pmid:17675267
|
Lam YM et al. |
Histone deacetylase inhibitors induce leukemia gene expression in cord blood hematopoietic stem cells expanded ex vivo. |
2017 |
Int. J. Hematol. |
pmid:27531147
|
Park H et al. |
Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells. |
2008 |
Int. J. Mol. Med. |
pmid:18949380
|
Inoue H et al. |
Histone deacetylase inhibitors sensitize human colonic adenocarcinoma cell lines to TNF-related apoptosis inducing ligand-mediated apoptosis. |
2002 |
Int. J. Mol. Med. |
pmid:11956660
|
Sachs LM et al. |
An essential role of histone deacetylases in postembryonic organ transformations in Xenopus laevis. |
2001 |
Int. J. Mol. Med. |
pmid:11712071
|
Ma J et al. |
Coxsackievirus and adenovirus receptor promotes antitumor activity of oncolytic adenovirus H101 in esophageal cancer. |
2012 |
Int. J. Mol. Med. |
pmid:22992863
|
Gray SG et al. |
Modulating IGFBP-3 expression by trichostatin A: potential therapeutic role in the treatment of hepatocellular carcinoma. |
2000 |
Int. J. Mol. Med. |
pmid:10601571
|
Shi Y et al. |
Histone deacetylase inhibitors alter the expression of molecular markers in breast cancer cells via microRNAs. |
2018 |
Int. J. Mol. Med. |
pmid:29620153
|
Wang Y et al. |
Effects of histone deacetylase inhibition on the survival, proliferation and migration of Schwann cells, as well as on the expression of neurotrophic factors and genes associated with myelination. |
2014 |
Int. J. Mol. Med. |
pmid:24888454
|
Andoh A et al. |
Modulation of complement component (C3 and factor B) biosynthesis by a histone deacetylase inhibitor in human intestinal epithelial cells. |
2000 |
Int. J. Mol. Med. |
pmid:10851266
|
Feng Q et al. |
Histone deacetylase inhibitors suppress RSV infection and alleviate virus-induced airway inflammation. |
2016 |
Int. J. Mol. Med. |
pmid:27460781
|
Guo Y et al. |
Trichostatin A attenuates oxidative stress-mediated myocardial injury through the FoxO3a signaling pathway. |
2017 |
Int. J. Mol. Med. |
pmid:28849190
|
Fukuoka M et al. |
Negative regulation of forkhead transcription factor AFX (Foxo4) by CBP-induced acetylation. |
2003 |
Int. J. Mol. Med. |
pmid:12964026
|
Kuribayashi T et al. |
Scriptaid, a novel histone deacetylase inhibitor, enhances the response of human tumor cells to radiation. |
2010 |
Int. J. Mol. Med. |
pmid:19956898
|
Hoever G et al. |
The mechanism of 3'-azido-2',3'-dideoxythymidine resistance to human lymphoid cells. |
2003 |
Int. J. Mol. Med. |
pmid:12736716
|
Huang J et al. |
Trichostatin A reduces cisplatin-induced ototoxicity through the STAT6 signaling pathway. |
2015 |
Int. J. Mol. Med. |
pmid:26080623
|
Qiang M et al. |
Epigenetic mechanisms are involved in the regulation of ethanol consumption in mice. |
2014 |
Int. J. Neuropsychopharmacol. |
pmid:25522411
|
Sakharkar AJ et al. |
Effects of histone deacetylase inhibitors on amygdaloid histone acetylation and neuropeptide Y expression: a role in anxiety-like and alcohol-drinking behaviours. |
2014 |
Int. J. Neuropsychopharmacol. |
pmid:24528596
|
Ma XH et al. |
Neuroprotective capabilities of TSA against cerebral ischemia/reperfusion injury via PI3K/Akt signaling pathway in rats. |
2015 |
Int. J. Neurosci. |
pmid:24730998
|
Takahashi K et al. |
Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer. |
2006 |
Int. J. Oncol. |
pmid:16391785
|
Bai T et al. |
A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells. |
2006 |
Int. J. Oncol. |
pmid:16391806
|
Hong X et al. |
Heparanase expression is associated with histone modifications in glioblastoma. |
2012 |
Int. J. Oncol. |
pmid:22001963
|
Kadaja-Saarepuu L et al. |
Tumor suppressor p53 down-regulates expression of human leukocyte marker CD43 in non-hematopoietic tumor cells. |
2012 |
Int. J. Oncol. |
pmid:21947346
|
You BR and Park WH |
Trichostatin A induces apoptotic cell death of HeLa cells in a Bcl-2 and oxidative stress-dependent manner. |
2013 |
Int. J. Oncol. |
pmid:23165748
|
Gray SG et al. |
Microarray profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines. |
2004 |
Int. J. Oncol. |
pmid:15010814
|
Sato K et al. |
Deficient expression of the DPD gene is caused by epigenetic modification in biliary tract cancer cells, and induces high sensitivity to 5-FU treatment. |
2006 |
Int. J. Oncol. |
pmid:16820886
|
Torres J et al. |
Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas. |
2010 |
Int. J. Oncol. |
pmid:20811720
|
Meng F et al. |
Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3. |
2013 |
Int. J. Oncol. |
pmid:23709006
|
Zhou C et al. |
Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. |
2006 |
Int. J. Oncol. |
pmid:16773209
|
Gahr S et al. |
The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells. |
2007 |
Int. J. Oncol. |
pmid:17671683
|
Yee SB et al. |
Trichostatin A induces apoptosis of p815 mastocytoma cells in histone acetylation- and mitochondria-dependent fashion. |
2004 |
Int. J. Oncol. |
pmid:15492835
|
Al-Nakhle H et al. |
Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region. |
2013 |
Int. J. Oncol. |
pmid:24068253
|
Yamanegi K et al. |
Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells. |
2015 |
Int. J. Oncol. |
pmid:25778932
|
Kang KA et al. |
Compound K, a metabolite of ginseng saponin, inhibits colorectal cancer cell growth and induces apoptosis through inhibition of histone deacetylase activity. |
2013 |
Int. J. Oncol. |
pmid:24100442
|
Meli M et al. |
Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3'-C-methyladenosine in leukaemia cells. |
2011 |
Int. J. Oncol. |
pmid:21318222
|
Imesch P et al. |
MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells. |
2009 |
Int. J. Oncol. |
pmid:19639184
|
Fortson WS et al. |
Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells. |
2011 |
Int. J. Oncol. |
pmid:21519790
|
Thelen P et al. |
Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells. |
2004 |
Int. J. Oncol. |
pmid:14654937
|
Li QQ et al. |
Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach. |
2016 |
Int. J. Oncol. |
pmid:27082124
|
Komata T et al. |
Histone deacetylase inhibitors, N-butyric acid and trichostatin A, induce caspase-8- but not caspase-9-dependent apoptosis in human malignant glioma cells. |
2005 |
Int. J. Oncol. |
pmid:15809727
|
Rho JH et al. |
Doxorubicin induces apoptosis with profile of large-scale DNA fragmentation and without DNA ladder in anaplastic thyroid carcinoma cells via histone hyperacetylation. |
2005 |
Int. J. Oncol. |
pmid:16010429
|
Choi YH |
Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells. |
2005 |
Int. J. Oncol. |
pmid:16010430
|
Noro R et al. |
PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors. |
2007 |
Int. J. Oncol. |
pmid:17912443
|
Svechnikova I et al. |
HDAC inhibitors effectively induce cell type-specific differentiation in human glioblastoma cell lines of different origin. |
2008 |
Int. J. Oncol. |
pmid:18360709
|
Asgar MA et al. |
Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines. |
2016 |
Int. J. Oncol. |
pmid:26575528
|
Stapnes C et al. |
Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in susceptibility to histone deacetylase inhibitors. |
2007 |
Int. J. Oncol. |
pmid:17982680
|
Carlisi D et al. |
Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects. |
2008 |
Int. J. Oncol. |
pmid:18097557
|
Park WH et al. |
Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis. |
2003 |
Int. J. Oncol. |
pmid:12684681
|
Sonnemann J et al. |
Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. |
2006 |
Int. J. Oncol. |
pmid:16465382
|
Lee EJ et al. |
Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells. |
2008 |
Int. J. Oncol. |
pmid:18813790
|
Byers J and Eichinger D |
Acetylation of the Entamoeba histone H4 N-terminal domain is influenced by short-chain fatty acids that enter trophozoites in a pH-dependent manner. |
2008 |
Int. J. Parasitol. |
pmid:17706222
|
Kumar A et al. |
γ-radiation induces cellular sensitivity and aberrant methylation in human tumor cell lines. |
2011 |
Int. J. Radiat. Biol. |
pmid:21815748
|
Biade S et al. |
Chemical agents that promote chromatin compaction radiosensitize tumour cells. |
2001 |
Int. J. Radiat. Biol. |
pmid:11682008
|
Sah NK et al. |
Effect of downregulation of survivin expression on radiosensitivity of human epidermoid carcinoma cells. |
2006 |
Int. J. Radiat. Oncol. Biol. Phys. |
pmid:17011457
|
Kim JH et al. |
Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor. |
2004 |
Int. J. Radiat. Oncol. Biol. Phys. |
pmid:15234053
|
Li GC et al. |
Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest. |
2006 |
Int. J. Urol. |
pmid:16771729
|
Sonnemann J et al. |
Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines. |
2005 |
Invest New Drugs |
pmid:15744585
|
Fraczek J et al. |
Screening of amide analogues of Trichostatin A in cultures of primary rat hepatocytes: search for potent and safe HDAC inhibitors. |
2009 |
Invest New Drugs |
pmid:18825314
|
Schwechter BR et al. |
Histone deacetylase inhibition-mediated differentiation of RGC-5 cells and interaction with survival. |
2007 |
Invest. Ophthalmol. Vis. Sci. |
pmid:17525221
|
Li H et al. |
Epigenetic regulation of CXCR4 expression by the ocular microenvironment. |
2013 |
Invest. Ophthalmol. Vis. Sci. |
pmid:23188729
|
Kashiwagi Y et al. |
Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines. |
2010 |
Invest. Ophthalmol. Vis. Sci. |
pmid:19737884
|
Crosson CE et al. |
Inhibition of histone deacetylase protects the retina from ischemic injury. |
2010 |
Invest. Ophthalmol. Vis. Sci. |
pmid:20164449
|
Wood JP et al. |
A comparison of differentiation protocols for RGC-5 cells. |
2010 |
Invest. Ophthalmol. Vis. Sci. |
pmid:20181845
|
Wallace DM et al. |
Histone deacetylase activity regulates apaf-1 and caspase 3 expression in the developing mouse retina. |
2006 |
Invest. Ophthalmol. Vis. Sci. |
pmid:16799012
|
Wang J et al. |
Effect of EGF-induced HDAC6 activation on corneal epithelial wound healing. |
2010 |
Invest. Ophthalmol. Vis. Sci. |
pmid:20089874
|
Xie L et al. |
Histone deacetylase inhibitors trichostatin A and vorinostat inhibit TGFβ2-induced lens epithelial-to-mesenchymal cell transition. |
2014 |
Invest. Ophthalmol. Vis. Sci. |
pmid:24994865
|
Klisovic DD et al. |
Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines. |
2003 |
Invest. Ophthalmol. Vis. Sci. |
pmid:12766035
|
Robertson DM et al. |
C-terminal cleavage of DeltaNp63alpha is associated with TSA-induced apoptosis in immortalized corneal epithelial cells. |
2010 |
Invest. Ophthalmol. Vis. Sci. |
pmid:20375332
|
Fan J et al. |
Inhibition of HDAC2 protects the retina from ischemic injury. |
2013 |
Invest. Ophthalmol. Vis. Sci. |
pmid:23696608
|
Sharma A et al. |
Trichostatin a inhibits corneal haze in vitro and in vivo. |
2009 |
Invest. Ophthalmol. Vis. Sci. |
pmid:19168895
|
Chen MH et al. |
A new trichostatin analog from Streptomyces sp. CPCC 203909. |
2015 |
J Asian Nat Prod Res |
pmid:25977996
|
Hutz JE et al. |
The multidimensional perturbation value: a single metric to measure similarity and activity of treatments in high-throughput multidimensional screens. |
2013 |
J Biomol Screen |
pmid:23204073
|
Jang B et al. |
Trichostatin A induces apoptosis in oral squamous cell carcinoma cell lines independent of hyperacetylation of histones. |
2018 |
J Cancer Res Ther |
pmid:30249871
|
Zhao W et al. |
A traditional Chinese medicine, Lujiao prescription, as a potential therapy for hypertrophic cardiomyocytes by acting on histone acetylation. |
2015 |
J Chin Med Assoc |
pmid:25913212
|
Marengo E et al. |
Use of Legendre moments for the fast comparison of two-dimensional polyacrylamide gel electrophoresis maps images. |
2005 |
J Chromatogr A |
pmid:16301071
|
Wu Y et al. |
Suppression of Excessive Histone Deacetylases Activity in Diabetic Hearts Attenuates Myocardial Ischemia/Reperfusion Injury via Mitochondria Apoptosis Pathway. |
2017 |
J Diabetes Res |
pmid:28191472
|
Duncan HF et al. |
Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells. |
2012 |
J Endod |
pmid:22341071
|
Tischler JL et al. |
Simple inhibitors of histone deacetylase activity that combine features of short-chain fatty acid and hydroxamic acid inhibitors. |
2008 |
J Enzyme Inhib Med Chem |
pmid:18608778
|
Zou Y et al. |
Effect of phenylhexyl isothiocyanate on aberrant histone H3 methylation in primary human acute leukemia. |
2012 |
J Hematol Oncol |
pmid:22747680
|
Bar-Nur O et al. |
Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives. |
2012 |
J Mol Cell Biol |
pmid:22430918
|
Klawitter M et al. |
Human MMP28 expression is unresponsive to inflammatory stimuli and does not correlate to the grade of intervertebral disc degeneration. |
2011 |
J Negat Results Biomed |
pmid:21801383
|
Mastitskaya S and Denecke B |
Human spongiosa mesenchymal stem cells fail to generate cardiomyocytes in vitro. |
2009 |
J Negat Results Biomed |
pmid:19903342
|
Wang H et al. |
Different effects of histone deacetylase inhibitors nicotinamide and trichostatin A (TSA) in C17.2 neural stem cells. |
2012 |
J Neural Transm |
pmid:22407380
|